DOCSLIB.ORG

Upsc October - 2020 Daily Current Affairs Class Test – 01 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Upsc October - 2020 Daily Current Affairs Class Test – 01 1 UPSC OCTOBER - 2020 DAILY CURRENT AFFAIRS CLASS TEST – 01 1. Consider the following pairs: above 80 years of age and people with Name of the Port Country disabilities, the Election Commission has 1. Sitwe Port - Myanmar come out with a set of new instructions. 2. Chabahar Port - Iran • The form required to opt for the postal 3. Gwadar Port - Pakistan ballot would be delivered at the residence 4. Hambantota Port - Sri Lanka of all those above 80 years of age and Which of the pairs given above are correct? people with disabilities by the booth level (a) 1, 2 and 3 only officer under his polling station. (b) 2, 3 and 4 only • It would be up to these two category of (c) 1, 3 and 4 only voters to opt for postal ballot. (d) All the above • Others who can avail the facility are as Answer: d) follows: Explanation: ✓ Members of the armed forces like the • All the above pairs are correctly matched. Army, Navy and Air Force, members of the armed police force of a state 2. Who among the following are eligible for (serving outside the state), government Postal Ballot System? employees posted outside India and 1. Members of the armed forces their spouses are entitled to vote only by 2. Spouses of government employees posted post. outside India ✓ In other words, they can’t vote in 3. Citizens above 80 years of age person. Voters under preventive 4. Persons under Preventive Detention detention can also vote only by post. 5. Persons under Punitive Detention ✓ Special voters such as the President of Select the correct answers using the code given India, Vice President, Governors, below: Union Cabinet ministers, Speaker of the (a) 1, 2 and 3 only House and government officers on poll (b) 2, 3 and 4 only duty have the option to vote by post. (c) 1, 2, 3 and 4 only ✓ But they have to apply through a (d) All the above prescribed form to avail this facility. Answer: c) Explanation: • Seeking to make the procedure to opt for postal ballot more convenient for those www.iasgatewayy.com Daily Current Affairs | Monthly 044- Magazines | Online Tests 1 | P a g e 26265326/9884421666/9884472636 UPSC OCTOBER - 2020 DAILY CURRENT AFFAIRS CLASS TEST – 01 3. Which of the following is/are not the • The 91st Amendment also barred the safeguards for the anti-defection law? appointment of defectors as Ministers until 1. The Anti-Defection Law provides a their disqualification period is over or they safeguard for defections made on genuine are re-elected, whichever is earlier. ideological differences. • But, obviously, such laws have not put to 2. It accepts split within a party if at least one- rest the trend of defections. third of the members of the legislative party defect. 4. Which of the following could be the reason/s 3. It also allows the formation of a new party for Current Account Deficit? or merger with other political party if not 1. Overvalued exchange rate less than two-thirds of the party’s members 2. Increase in exports commit to it. 3. Long periods of consumer-led Economic Select the correct answer using the code given growth below: 4. High inflation a) 2 only Choose the correct option: b) 2 and 3 only (a) 1, 3 and 4 only c) 3 only (b) 2, 3 and 4 only d) 1, 2 and 3 (c) 2 only Answer: d (d) 1 and 4 only Explanation: Answer: a) • The Anti-Defection Law provided a Explanation: safeguard for defections made on genuine • The current account deficit is a ideological differences. measurement of a country’s trade where the • It accepted “split” within a party if at least value of the goods and services it imports one-third of the members of the legislative exceeds the value of its exports. party defect, and allowed the formation of • If the currency is overvalued, imports will a new party or “merger” with other political be cheaper, and therefore there will be a party if not less than two-thirds of the higher quantity of imports resulting in a party’s members commit to it. Current Account Deficit. • The 91st Constitutional Amendment • One of the reasons for the Current Account introduced in 2003 deleted the provision Surplus is an increase in exports. allowing split. www.iasgatewayy.com Daily Current Affairs | Monthly 044- Magazines | Online Tests 2 | P a g e 26265326/9884421666/9884472636 UPSC OCTOBER - 2020 DAILY CURRENT AFFAIRS CLASS TEST – 01 • A period of consumer-led economic • Brahmos is named after the rivers growth will cause deterioration in the Brahmaputra of India and Moskva of current account. Higher consumer Russia. spending will lead to higher spending on • BrahMos is a two-stage missile with a solid imports. The recession of 2009 also led to propellant booster engine as its first stage a temporary improvement in the deficit as which brings it to supersonic speed and consumers cut back on spending. then gets separated. The liquid ramjet or the • If a country’s inflation rises faster than its second stage then takes the missile closer to main competitors then it will make the 3 Mach speed in cruise phase. exports less competitive and imports more • It can be launched from land, air, and sea. competitive for that country. This will lead 6. Consider the following statements with respect to deterioration in the current account. to Copernicus Programme: 5. Consider the following statements with respect 1. It is an Earth observation programme. to BrahMos: 2. The programme is co-ordinated and 1. It is a supersonic cruise missile developed managed by National Aeronautics and by the Defence Research and Development Space Administration (NASA). Organisation of India (DRDO) and Russia. 3. It was previously known as Global 2. It is a two-stage missile with a solid Monitoring for Environment and Security propellant engine in the first stage and a programme (GMES). liquid ramjet in the second. Which of the given statement/s is/are correct? 3. It can be launched from land, air, and sea. (a) 1 only Which of the given statement/s is/are correct? (b) 1 and 3 only (a) 1 only (c) 1, 2 and 3 only (b) 1 and 3 only (d) 1 and 2 only (c) 1, 2 and 3 Answer: b) (d) 1 and 2 only Explanation: Answer: c) • Copernicus is an ambitious Earth Explanation: observation programme. • BrahMos is a joint venture between the • It is coordinated and managed by the Defence Research and Development European Commission in partnership with Organisation of India (DRDO) and the the European Space Agency, the EU NPOM of Russia. Member States and EU Agencies. www.iasgatewayy.com Daily Current Affairs | Monthly 044- Magazines | Online Tests 3 | P a g e 26265326/9884421666/9884472636 UPSC OCTOBER - 2020 DAILY CURRENT AFFAIRS CLASS TEST – 01 • Copernicus is the new name for the Global • The Alliance intends to advocate for Monitoring for Environment and Security freedom of religion or belief for all, which programme, previously known as GMES. includes the right of individuals to hold any belief or none, to change religion or belief 7. Which of the following country has recently and to manifest religion or belief, either launched the International Religious Freedom alone or in community with others, in Alliance? worship, observance, practice and (a) USA teaching. (b) India • The Alliance is intended to bring together (c) Russia senior government representatives to (d) China discuss actions their nations can take Answer: a) together to promote respect for freedom of Explanation: religion or belief and protect members of International Religious Freedom Alliance: religious minority groups worldwide. • The United States has recently announced the launch of a 27-nation International 8. Which of the following have been given the Religious Freedom Alliance, which will try Geographical Indication Tag? to adopt a collective approach in protecting 1. Sawantwadi toys and preserving religious freedom across the 2. Channapatna toys world. 3. Etikoppaka toys • Among the prominent countries to join the 4. Kondapalli toys alliance are Austria, Brazil, the United 5. Kinhal toys Kingdom, Israel, Ukraine, the Netherlands Choose the correct option: and Greece. (a) 1, 2, 3 and 4 only • The Alliance is a network of likeminded (b) 2, 3, 4 and 5 only countries fully committed to advancing (c) 2, 3 and 5 only freedom of religion or belief around the (d) 2 and 4 only world. Answer: b) • The Alliance is predicated on the idea more Explanation: must be done to protect members of • Channapatna toys – Karnataka, Etikoppa religious minority groups and combat Toys and Kondapalli Bommalu (Toys) – discrimination and persecution based on Andhra Pradesh have been given the religion or belief. Geographical Indication Tag. www.iasgatewayy.com Daily Current Affairs | Monthly 044- Magazines | Online Tests 4 | P a g e 26265326/9884421666/9884472636 UPSC OCTOBER - 2020 DAILY CURRENT AFFAIRS CLASS TEST – 01 • Sawantwadi toys refer to handmade works winter and spring were warmer than usual of art made of wood in Sawantwadi, a town during 2019-20. in Sindhudurg district of Maharashtra. • Temperature in Siberia in 2020 had gone • To mark the occasion of 151 years of through the roof, with the region recording postcards in India, Maharashtra Circle of a severe heatwave. India Post will release picture postcards on • Nearly all of this year’s fires inside the ‘Sawantwadi Toys’. The postcard is Arctic Circle occurred on continuous inspired by the Prime Minister’s speech on permafrost, with over half of these burning the country’s ability to become a “toy hub”. on ancient carbon-rich peat soils. • The tundra is drying up and vegetation 9.
Load more

Recommended publications
  • Viral Hepatitis Testing Effective Date: January 1, 2012
    Viral Hepatitis Testing Effective Date: January 1, 2012 Scope This guideline provides guidance for the use of laboratory tests to diagnose acute and chronic viral hepatitis in adults (> 19 years) in the primary care setting. General Considerations for Ordering Laboratory Tests Prior to ordering tests for hepatitis, consider the patient’s history, age, risk factors (see below), hepatitis vaccination status, and any available previous hepatitis test results. Risk Factors for Viral Hepatitis include: • Substance use (includes sharing drug snorting, smoking or injection equipment) • High-risk sexual activity or sexual partner with viral hepatitis • Travel to or from high-risk hepatitis endemic areas or exposure during a local outbreak • Immigration from hepatitis B and/or C endemic countries • Household contact with an infected person especially if personal items (e.g., razors, toothbrushes, nail clippers) are shared • Recipient of unscreened blood products* • Needle-stick injury or other occupational exposure (e.g., healthcare workers) • Children born to mothers with chronic hepatitis B or C infection • Attendance at daycare • Contaminated food or water (hepatitis A only) • Tattoos and body piercing • History of incarceration • HIV or other sexually transmitted infection • Hemodialysis *screening of donated blood products for hepatitis C (anti-HCV) began in 1990 in Canada.1 Types of Viral Hepatitis Hepatitis A: causes acute but not chronic hepatitis Hepatitis B: causes acute and chronic hepatitis Hepatitis C: causes chronic hepatitis but rarely manifests as acute hepatitis Hepatitis D: rare and only occurs in patients infected with hepatitis B Hepatitis E: clinically similar to hepatitis A, mostly restricted to endemic areas and occasionally causes chronic infection in immunosuppressed people Others: e.g.
    [Show full text]
  • The Use of Non-Human Primates in Research in Primates Non-Human of Use The
    The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations.
    [Show full text]
  • Rational Engineering of HCV Vaccines for Humoral Immunity
    viruses Review To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity Felicia Schlotthauer 1,2,†, Joey McGregor 1,2,† and Heidi E Drummer 1,2,3,* 1 Viral Entry and Vaccines Group, Burnet Institute, Melbourne, VIC 3004, Australia; [email protected] (F.S.); [email protected] (J.M.) 2 Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia 3 Department of Microbiology, Monash University, Clayton, VIC 3800, Australia * Correspondence: [email protected]; Tel.: +61-392-822-179 † These authors contributed equally to this work. Abstract: Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030. A prophylactic vaccine remains a high priority. Whilst early vaccines focused largely on generating T cell immunity, attention is now aimed at vaccines that gen- erate humoral immunity, either alone or in combination with T cell-based vaccines. High-resolution structures of hepatitis C viral glycoproteins and their interaction with monoclonal antibodies isolated from both cleared and chronically infected people, together with advances in vaccine technologies, provide new avenues for vaccine development. Keywords: glycoprotein E2; vaccine development; humoral immunity Citation: Schlotthauer, F.; McGregor, J.; Drummer, H.E To Include or 1. Introduction Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity. The development of direct-acting antiviral agents (DAA) with their ability to cure Viruses 2021, 13, 805. https:// infection in >95% of those treated was heralded as the key to eliminating hepatitis C globally.
    [Show full text]
  • Research Directions After the First Hepatitis C Vaccine Efficacy Trial
    viruses Review Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial Christopher C. Phelps 1 , Christopher M. Walker 1,2 and Jonathan R. Honegger 1,2,*,† 1 Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH 43205, USA; [email protected] (C.C.P.); [email protected] (C.M.W.) 2 Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43210, USA * Correspondence: [email protected] † Current address: Abigail Wexner Research Institute at Nationwide Children’s Hospital, 700 Children’s Drive, WA4020, Columbus, OH 43205, USA. Abstract: Thirty years after its discovery, the hepatitis C virus (HCV) remains a leading cause of liver disease worldwide. Given that many countries continue to experience high rates of transmission despite the availability of potent antiviral therapies, an effective vaccine is seen as critical for the elimination of HCV. The recent failure of the first vaccine efficacy trial for the prevention of chronic HCV confirmed suspicions that this virus will be a challenging vaccine target. Here, we examine the published data from this first efficacy trial along with the earlier clinical and pre-clinical studies of the vaccine candidate and then discuss three key research directions expected to be important in ongoing and future HCV vaccine development. These include the following: 1. design of novel immunogens that generate immune responses to genetically diverse HCV genotypes and subtypes, 2. strategies to elicit broadly neutralizing antibodies against envelope glycoproteins in addition to cytotoxic and helper T cell responses, and 3.
    [Show full text]
  • All Qatar Residents to Get Covid Vaccine Free
    INDEX QATAR 2-6,12 COMMENT 10 BUSINESS | Page 1 QATAR | Page 12 ARAB WORLD 7 BUSINESS 1-12 Qatar private INTERNATIONAL 7-9,11 SPORTS 1-8 Last Covid-19 sector bounces DOW JONES QE NYMEX patient back on lift ing discharged 28,148.64 9,956.66 39.36 of Covid-19 +465.83 +3.15 +2.31 from Lebsear +1.68% +0.03% +6.23% curbs: QFC Latest Figures Field Hospital published in QATAR since 1978 TUESDAY Vol. XXXXI No. 11693 October 6, 2020 Safar 19, 1442 AH GULF TIMES www. gulf-times.com 2 Riyals PM offers condolences to Amir of Kuwait HE the Prime Minister and Minister of Interior Sheikh Khalid bin Khalifa bin Abdulaziz al-Thani yesterday off ered condolences to the Amir of Kuwait, Sheikh Nawaf al-Ahmad al-Jaber al-Sabah, on the death of Sheikh Sabah al-Ahmad al-Jaber al-Sabah, praying to Allah to have mercy on the soul of the deceased and to rest it in peace in Paradise. The prime minister also off ered condolences to members of the ruling family and ranking off icials. Ministers and members of the off icial delegation accompanying the prime minister also off ered their condolences. Two held for violating PM meets Afghan president home quarantine rules Competent authorities arrested yesterday two people who violated All Qatar residents to the requirements of the home quarantine, which they committed to following, in accordance with the procedures of the health authorities in the country. The get Covid vaccine free two persons being referred to prosecution are: Albert Mondano Oshavillo and Nasser Ghaidan By Ayman Adly is not yet clear whether the upcoming Mohamed al-Hatheeth al-Qahtani.
    [Show full text]
  • 1 Title: Interim Report of a Phase 2 Randomized Trial of a Plant
    medRxiv preprint doi: https://doi.org/10.1101/2021.05.14.21257248; this version posted May 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. 1 Title: Interim Report of a Phase 2 Randomized Trial of a Plant-Produced Virus-Like Particle 2 Vaccine for Covid-19 in Healthy Adults Aged 18-64 and Older Adults Aged 65 and Older 3 Authors: Philipe Gobeil1, Stéphane Pillet1, Annie Séguin1, Iohann Boulay1, Asif Mahmood1, 4 Donald C Vinh 2, Nathalie Charland1, Philippe Boutet3, François Roman3, Robbert Van Der 5 Most4, Maria de los Angeles Ceregido Perez3, Brian J Ward1,2†, Nathalie Landry1† 6 Affiliations: 1 Medicago Inc., 1020 route de l’Église office 600, Québec, QC, Canada, G1V 7 3V9; 2 Research Institute of the McGill University Health Centre, 1001 Decarie St, Montreal, 8 QC H4A 3J1; 3 GlaxoSmithKline Biologicals SA (Vaccines), Avenue Fleming 20, 1300 Wavre, 9 Belgium; 4 GlaxoSmithKline Biologicals SA (Vaccines), rue de l’Institut 89, 1330 Rixensart, 10 Belgium; † These individuals are equally credited as senior authors. 11 * Corresponding author: Nathalie Landry, 1020 Route de l’Église, Bureau 600, Québec, Qc, 12 Canada, G1V 3V9; Tel. 418 658 9393; Fax. 418 658 6699; [email protected] 13 Abstract 14 The rapid spread of SARS-CoV-2 globally continues to impact humanity on a global scale with 15 rising morbidity and mortality. Despite the development of multiple effective vaccines, new 16 vaccines continue to be required to supply ongoing demand.
    [Show full text]
  • Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines
    Review Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines Puna Maya Maharjan 1 and Sunghwa Choe 2,3,* 1 G+FLAS Life Sciences, 123 Uiryodanji-gil, Osong-eup, Heungdeok-gu, Cheongju-si 28161, Korea; punamaya.maharjan@gflas.com 2 G+FLAS Life Sciences, 38 Nakseongdae-ro, Gwanak-gu, Seoul 08790, Korea 3 School of Biological Sciences, College of Natural Sciences, Seoul National University, Gwanak-gu, Seoul 08826, Korea * Correspondence: [email protected] Abstract: The prevalence of the coronavirus disease 2019 (COVID-19) pandemic in its second year has led to massive global human and economic losses. The high transmission rate and the emergence of diverse SARS-CoV-2 variants demand rapid and effective approaches to preventing the spread, diagnosing on time, and treating affected people. Several COVID-19 vaccines are being developed using different production systems, including plants, which promises the production of cheap, safe, stable, and effective vaccines. The potential of a plant-based system for rapid production at a commercial scale and for a quick response to an infectious disease outbreak has been demonstrated by the marketing of carrot-cell-produced taliglucerase alfa (Elelyso) for Gaucher disease and tobacco- produced monoclonal antibodies (ZMapp) for the 2014 Ebola outbreak. Currently, two plant-based COVID-19 vaccine candidates, coronavirus virus-like particle (CoVLP) and Kentucky Bioprocessing (KBP)-201, are in clinical trials, and many more are in the preclinical stage. Interim phase 2 clinical Citation: Maharjan, P.M.; Choe, S. trial results have revealed the high safety and efficacy of the CoVLP vaccine, with 10 times more Plant-Based COVID-19 Vaccines: neutralizing antibody responses compared to those present in a convalescent patient’s plasma.
    [Show full text]
  • Information & Consent Form
    INFORMATION & CONSENT FORM RESEARCH TITLE: A Randomized, Observer-Blind, Placebo-Controlled, Phase 2/3 Study to Assess the Safety, Efficacy, and Immunogenicity of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults 18 Years of Age or Older SHORT TITLE: A randomized controlled study, assessing the safety and immunogenicity of a COVID-19 vaccine in adults PROTOCOL NUMBER: CP-PRO-CoVLP-021 RESEARCHERS: Principal Investigator: Dr. Scott Halperin, Pediatric Infectious Disease Specialist, IWK Health Centre Co-Investigators: Dr. Joanne Langley, Pediatric Infectious Disease Specialist, IWK Health Centre Dr. Jeannette Comeau, Pediatric Infectious Disease Specialist, IWK Health Centre FUNDER: Medicago R&D Inc. SPONSOR: Medicago R&D Inc. 1020 route de l’Église, bureau 600 Québec (QC), Canada G1V 3V9 Introduction You are being asked to take part in this research study to assess the safety and ability of an investigational study vaccine to generate an immune response against the virus causing COVID-19 disease. You can decide if you want to take part in this study or not. Your choice will not change the quality of care that you will receive outside of this study. Please take time to read the following information about the study. Feel free to ask the study staff any questions that you may have. Informed consent means agreeing to take part in a research study, but only when you fully understand what this means for you. You sign this informed consent form only if you agree to take part in this study. Signing the form shows that you have understood what this means for you and that you want to take part.
    [Show full text]
  • Revisiting the Elusive Hepatitis C Vaccine
    Editorial Revisiting the Elusive Hepatitis C Vaccine Stephen M. Todryk 1,2,* , Margaret F. Bassendine 2,* and Simon H. Bridge 1,2,* 1 Faculty of Health & Life Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK 2 Translational & Clinical Research Institute, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK * Correspondence: [email protected] (S.M.T.); [email protected] (M.F.B.); [email protected] (S.H.B.) The impactful discovery and subsequent characterisation of hepatitis C virus (HCV), an RNA virus of the flavivirus family, led to the awarding of the 2020 Nobel Prize in Physiology or Medicine to Harvey J. Alter, Michael Houghton and Charles M. Rice [1]. However, despite the significant advances recognised by this Nobel prize, an effective HCV vaccine remains elusive. The recent success of vaccines against SARS-CoV-2, developed with unprecedented speed, has shone a bright light on the vaccination process for protection against viral threats and may provide renewed impetus for the development of vaccines for other viruses. HCV infection remains a major global health problem as approximately three quarters of those infected develop chronic infection, leading to morbidity and mortality due to progressive liver fibrosis, cirrhosis and cancer. The World Health Organization (WHO) estimates that 71.1 million people are living with chronic HCV, resulting in over 400,000 deaths every year. In 2016, the WHO adopted a global strategy with the aim of eliminating viral hepatitis as a public health problem, comprising targets to reduce new viral hepatitis infections by 90% and reduce deaths due to viral hepatitis by 65% by 2030.
    [Show full text]
  • Molecular Communications in Viral Infections Research: Modelling
    Molecular Communications in Viral Infections Research: Modelling, Experimental Data and Future Directions Michael Taynnan Barros∗, Mladen Veletic´∗, Masamitsu Kanada, Massimiliano Pierobon, Seppo Vainio, Ilangko Balasingham, Sasitharan Balasubramaniam Abstract—Hundreds of millions of people worldwide are af- people have contracted the disease resulting in just over a fected by viral infections each year, and yet, several of them million deaths, with a a mortality rate of approximately 4%. neither have vaccines nor effective treatment during and post- During the first months of the pandemic, global stock markets infection. This challenge has been highlighted by the COVID- 19 pandemic, showing how viruses can quickly spread and experienced their worst crash since 1987, in the first three impact society as a whole. Novel interdisciplinary techniques months of 2020 the G20 economies fell by 3.4% year-on- must emerge to provide forward-looking strategies to combat year, an estimated 400 million full-time jobs were lost across viral infections, as well as possible future pandemics. In the the world, and income earned by workers globally fell 10%, past decade, an interdisciplinary area involving bioengineering, where all of this effects is equivalent to a loss of over US$3.5 nanotechnology and information and communication technology (ICT) has been developed, known as Molecular Communications. trillion [1]. As a result, governments around the world have This new emerging area uses elements of classical communication quickly formulated new recovery plans, where for example systems to molecular signalling and communication found inside in the EU, an investment of 750 billion euros is set to bring and outside biological systems, characterizing the signalling the continent back to normality within the first half of the processes between cells and viruses.
    [Show full text]
  • समाचार प से च यत अंश Newspapers Clippings
    Feb 2021 समाचार प�� से च�यत अंश Newspapers Clippings A Daily service to keep DRDO Fraternity abreast with DRDO Technologies, Defence Technologies, Defence Policies, International Relations and Science & Technology खंड : 46 अंक : 26 05 फरवर� 2021 Vol.: 46 Issue : 26 05 February 2021 र�ा �व�ान पु�तकालय Defenceर�ा �व�ान Science पु�तकालय Library र�ा Defenceवै�ा�नक स Scienceूचना एवं �लेखन Library क� � Defence Scientificर�ा Informationवै�ा�नक सूचना &एवं Documentation �लेखन क� � Centre Defence Scientificमेटकॉफ Information हाउस, �द�ल� &- Documentation110 054 Centre Metcalfeमेटकॉफ House,हाउस, �द�ल� Delhi ­- 110110 054 054 Metcalfe House, Delhi­ 110 054 CONTENTS S. No. TITLE Page No. DRDO News 1-13 DRDO at Aero India 2021 1-13 1. DRDO’s International Seminar on “Energising R&D capabilities towards 1 Atmanirbhar Bharat” 2. HAL receives request for Proposal for 70 HTT-40 Basic Trainer Aircraft from 2 Indian Air Force at Aero India 2021 3. एचएएल ने एयरो इं�डया 2021 म� भारतीय वायसेनाु से 70 एचट�ट�-40 बे�सक �ेनर एयर�ा�ट के 3 ��ताव के �लए अनरोधु �ा�त �कया 4. India most attractive centre for R&D, says defence secy 4 5. Aatmanirbhar Bharat: India's defence PSUs cutting-edge innovations on display at 5 Aero India 2021 6. Tejas, BrahMos and Astra among 156 defence items cleared for exports 6 7. Thrilled to fly homegrown fighter jet Tejas, the pride of Bengaluru: MP Tejasvi 8 Surya 8. भारत म� �न�म�त ‘तेजस’ म� तेज�वी सूया� ने उड़ान भर� 9 9.
    [Show full text]
  • Small Launchers in a Pandemic World - 2021 Edition of the Annual Industry Survey
    SSC21- IV-07 Small Launchers in a Pandemic World - 2021 Edition of the Annual Industry Survey Carlos Niederstrasser Northrop Grumman Corporation 45101 Warp Drive, Dulles, VA 20166 USA; +1.703.406.5504 [email protected] ABSTRACT Even with the challenges posed by the world-wide COVID pandemic, small vehicle "Launch Fever" has not abated. In 2015 we first presented this survey at the AIAA/USU Conference on Small Satellites1, and we identified twenty small launch vehicles under development. By mid-2021 ten vehicles in this class were operational, 48 were identified under development, and a staggering 43 more were potential new entrants. Some are spurred by renewed government investment in space, such as what we see in the U.K. Others are new commercial entries from unexpected markets such as China. All are inspired by the success of SpaceX and the desire to capitalize on the perceived demand caused by the mega constellations. In this paper we present an overview of the small launch vehicles under development today. When available, we compare their capabilities, stated mission goals, cost and funding sources, and their publicized testing progress. We also review the growing number of entrants that have dropped out since we first started this report. Despite the COVID-19 pandemic, one system became operational in the past 12 months and two or three more systems hope to achieve their first successful launch in 2021. There is evidence that this could be the year when the small launch market finally becomes saturated; however, expectations continue to be high and many new entrants hope that there is room for more providers.
    [Show full text]